LGALS9 and B-cell non-Hodgkin lymphoma: Correspondingly, Gal-9 treatment increased lysotracker and Cyto-ID signals in B cell lymphoma cells, indicative of the involvement of the lysosomal and autophagosomal pathway (Figures 2A,B).